Thanks Ohm. That helped. This brings me to a
Post# of 155128
This brings me to another question that I keep thinking about. I think it was the March shareholders letter or no I think it was a press release possibly in Munich talking about the “new MOA” where LL primes cold tumors to express PDL one. I think there was a mention there of DNA repair. I’ve asked this question to several oncologists who found it to be intriguing and I don’t think they gave me an answer that I found satisfying, but I’ll post it here and would like your input home or anyone else’s who might have an answer or a theory.
What role does DNA degradation play in cancer and does PDL one play a role? Also what impact does LL have on DNA repair and what DNA are we talking about? I did some research months ago when my uncle had glioblastoma and found a company out of Massachusetts called BPGbio that has a 96 hour infusion for a product yet to be approved that seemed to “prime” cells for DNA repair and I think it’s specific to mitochondrial DNA repair.. my thinking at the time was that LL could have a synergistic effect with this product. Does the DNA repair that CYDY discussed have a similar MOA to this product from BPG? If they are different, how?
It’s been many years since I studied molecular biology and molecular genetics, but I did speak to the CEO of that company and he explained the science to me, and I followed the best I could, but because I hadn’t studied it in advance I didn’t understand him and had to really dig deep to learn a little more. Which wasn’t much.
Thanks in advance for any feedback

